Avinger, Inc. (AVGR) DCF Valuation

Avinger, Inc. (AVGR) DCF Valuation

US | Healthcare | Medical - Instruments & Supplies | NASDAQ
Avinger, Inc. (AVGR) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Avinger, Inc. (AVGR) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Avinger, Inc.'s (AVGR) financial prospects like an expert! This (AVGR) DCF Calculator provides pre-filled financial data and offers full flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your predictions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 9.1 8.8 10.1 8.3 7.7 7.4 7.1 6.9 6.6 6.4
Revenue Growth, % 0 -4.05 15.63 -18.33 -7.51 -3.57 -3.57 -3.57 -3.57 -3.57
EBITDA -16.4 -16.4 -17.4 -15.8 -16.3 -7.4 -7.1 -6.9 -6.6 -6.4
EBITDA, % -179.65 -187.39 -171.91 -190.51 -213.62 -100 -100 -100 -100 -100
Depreciation 1.6 1.9 1.7 1.3 .3 1.1 1.1 1.0 1.0 1.0
Depreciation, % 17.15 21.23 16.65 15.67 3.78 14.9 14.9 14.9 14.9 14.9
EBIT -18.0 -18.3 -19.1 -17.1 -16.6 -7.4 -7.1 -6.9 -6.6 -6.4
EBIT, % -196.8 -208.62 -188.56 -206.18 -217.39 -100 -100 -100 -100 -100
Total Cash 10.9 22.2 19.5 14.6 5.3 6.9 6.7 6.4 6.2 6.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.5 1.5 1.4 1.1 1.0
Account Receivables, % 15.97 16.94 13.75 12.78 13.25
Inventories 3.9 3.9 4.6 5.0 5.3 3.9 3.7 3.6 3.5 3.3
Inventories, % 42.84 44.24 45.42 60.01 69.24 52.35 52.35 52.35 52.35 52.35
Accounts Payable .7 .7 1.4 .6 .8 .7 .7 .6 .6 .6
Accounts Payable, % 7.26 7.92 13.76 7.63 10.15 9.34 9.34 9.34 9.34 9.34
Capital Expenditure -.1 .0 .0 -.1 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -0.96375 0 -0.33564 -0.61646 -0.10455 -0.40408 -0.40408 -0.40408 -0.40408 -0.40408
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -18.2 -19.1 -22.7 -16.9 -16.6 -7.4 -7.1 -6.8 -6.6 -6.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -21.5 -17.2 -21.0 -16.4 -16.5 -5.0 -5.9 -5.7 -5.5 -5.3
WACC, % 11.11 11.11 11.11 10.99 11.11 11.08 11.08 11.08 11.08 11.08
PV UFCF
SUM PV UFCF -20.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -5
Terminal Value -60
Present Terminal Value -35
Enterprise Value -55
Net Debt 10
Equity Value -66
Diluted Shares Outstanding, MM 1
Equity Value Per Share -83.42

What You Will Get

  • Real AVGR Financials: Access to both historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures to fit your analysis.
  • Dynamic Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Evaluate various scenarios to assess Avinger’s potential future performance.
  • User-Friendly Design: Designed for professionals but easy to navigate for newcomers.

Key Features

  • Customizable Financial Inputs: Adjust essential metrics such as revenue projections, gross margins, and operational costs.
  • Instant DCF Valuation: Automatically computes intrinsic value, NPV, and other financial metrics in real-time.
  • High-Precision Accuracy: Leverages Avinger, Inc.'s (AVGR) actual financial data for reliable valuation results.
  • Streamlined Scenario Analysis: Easily evaluate various assumptions and analyze their impacts on outcomes.
  • Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.

How It Works

  • Download: Obtain the pre-built Excel file featuring Avinger, Inc.'s (AVGR) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and compare results instantly.
  • Make Decisions: Utilize the valuation outcomes to inform your investment strategy.

Why Choose Avinger, Inc. (AVGR)?

  • Innovative Solutions: Cutting-edge technology designed to improve patient outcomes.
  • Proven Expertise: Backed by a team of industry professionals with extensive experience.
  • Patient-Centric Approach: Focused on enhancing the quality of care for patients.
  • Comprehensive Support: Robust resources and training to ensure successful implementation.
  • Industry Recognition: A trusted name in the medical device sector with numerous accolades.

Who Should Use Avinger, Inc. (AVGR)?

  • Healthcare Professionals: Understand the latest advancements in vascular technology and their applications.
  • Researchers: Utilize Avinger's innovative models in clinical studies and medical research.
  • Investors: Evaluate market trends and assess the growth potential of Avinger, Inc. (AVGR).
  • Medical Device Analysts: Enhance your analysis with detailed insights on Avinger's product offerings.
  • Medical Practitioners: Discover how Avinger, Inc. (AVGR) is transforming patient care through innovative solutions.

What the Template Contains

  • Pre-Filled Data: Contains Avinger, Inc.'s historical financials and projections.
  • Discounted Cash Flow Model: An editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on user-defined inputs.
  • Key Financial Ratios: Evaluate Avinger, Inc.'s profitability, efficiency, and leverage metrics.
  • Customizable Inputs: Easily modify revenue growth, profit margins, and tax rates.
  • Clear Dashboard: Visual representations and tables summarizing key valuation outcomes.

Es wurden keine passenden Produkte gefunden.